Recent advances in the management of preeclampsia

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 6, Issue 1, 1997, Pages 6-15

  Lewis, Rani ^a   Sibai, Baha ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Expectant management; Outpatient management; Seizure prophylaxis

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM; MAGNESIUM SULFATE;

ANTICONVULSANT THERAPY; ARTICLE; DIET SUPPLEMENTATION; FEMALE; FETUS MONITORING; HUMAN; OUTPATIENT; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL;

ANTICONVULSANTS; ASPIRIN; BED REST; CALCIUM; CYCLOOXYGENASE INHIBITORS; FEMALE; HOSPITALIZATION; HUMANS; MAGNESIUM SULFATE; PLATELET AGGREGATION INHIBITORS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, THIRD; RANDOMIZED CONTROLLED TRIALS; SEIZURES;

EID: 0031034947     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: 10.3109/14767059709161944     Document Type: Article

References (49)

1. Hughes HC (ed): "Obstetric-Gynecologic Terminology." Philadelphia: F.A. Davis Company, pp 422-423, 1972.
2. American College of Obstetricians and Gynecologists: "Management of Preeclampsia." Washington, DC: American College of Obstetricians and Gynecologists, Technical Bulletin 91, 1986.
3. Sibai BM: Management of preeclampsia. Clin Perinatol 18:793-808, 1991.
4. Gilstrap LC, Cunningham GF, Whalley PJ: Management of pregnancy induced hypertension in the nulliparous patient remote from term. Semin Perinatol 2:73-81, 1978.
5. Mathews DD: A randomized controlled trial of bed rest and sedation or normal activity and non-sedation in the management of non-albuminuric hypertension in late pregnancy. Br J Obstet Gynaecol 84:108-110, 1977.
6. Feeney JG: Hypertension in pregnancy managed by community midwives. BMJ 288:1046-1050, 1984.
7. Tuffnell DJ, Lilford RJ, Buchan PC, Prendiville VM, Tuffnell AJ, Holgate MP, Griffith-Jones MD: Randomised controlled trial of day care for hypertension in pregnancy. Lancet 339:224-227, 1992.
8. Crowther CA, Bouwmeester AM, Ashurst HM: Does admission to hospital for bed rest prevent disease progression or improve fetal outcome in pregnancy complicated by non-proteinuric hypertension? Br J Obstet Gynaecol 99:13-17, 1992.
9. Barton JR, Stanziano GJ, Sibai BM: Monitored outpatient management of mild gestational hypertension remote from term. Am J Obstet Gynecol 170:765-769, 1994.
10. Helewa M, Heaman M, Robinson MA, Thompson L: Community-based home-care program for the management of pre-eclampsia: An alternative. Can Med Assoc J 149:829-834, 1993.
11. Schiff E, Friedman SA, Sibai BM: Conservative management of severe preeclampsia remote from term. Obstet Gynecol 84:626-630, 1994.
12. Railton A, Allen DG: Management and outcome of pregnancy complicated by severe pre-eclampsia of early onset. S Afr Med J 72:608-610, 1987.
13. Pattinson RC, Odendaal HJ, du Toit R: Conservative management of severe proteinuric hypertension before 28 weeks' gestation. S Afr Med J 73:516-518, 1988.
14. Banias BB, Devoe LD, Nolan TE: Severe preeclampsia in preterm pregnancy between 26 and 32 weeks' gestation. Am J Perinatol 9:357-360, 1992.
15. Olah KS, Redman CW, Gee H: Management of severe, early preeclampsia: Is conservative management justified? Eur J Obstet Gynecol Reprod Biol 51:175-180, 1994.
16. Moodley J, Korateng SA, Rout C: Expectant management of early onset of severe pre-eclampsia in Durban. S Afr Med J 83:584-587, 1993.
17. Sibai BM, Taslimi M, Abella TN, Brooks TF, Spinnato JA, Anderson GD: Maternal and perinatal outcome of conservative management of severe preeclampsia in midtrimester. Am J Obstet Gynecol 152:32-37, 1985.
18. Wisser W, van Pampus MG, Tretters PE, Walleburg HC: Perinatal results of hemodynamic and conservative temporizing treatment in severe pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 53:175-181.
19. Sibai BM, Akl S, Fairlie F, Moretti M: A protocol for managing severe preeclampsia in the second trimester. Am J Obstet Gynecol 163:733-738, 1990.
20. Odendaal HJ, Pattinson RC, Bam R, Grove D, Kotze TJ: Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: A randomized controlled trial. Obstet Gynecol 76:1070-1075, 1990.
21. Sibai BM, Mercer BM, Schiff E, Friedman SA: Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: A randomized controlled trial. Am J Obstet Gynecol 171:818-822, 1994.
22. Fenakel K, Fenakel G, Appelman Z, Lurie S, Katz Z, Shoham Z: Nifedipine in the treatment of severe preeclampsia. Obstet Gynecol 77:331-337, 1991.
23. Pritchard JA, Cunningham FG, Pritchard SA: The Parkland Memorial Hospital protocol for treatment of eclampsia: Evaluation of 245 cases. Am J Obstet Gynecol 148:951-963, 1984.
24. Lucas MJ, Leveno KJ, Cunningham FG: A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 333:201-205, 1995.
25. Moodley J, Moodley W: Prophylactic anticonvulsant therapy in hypertensive crises of pregnancy - the need for a large, randomized trial. Hyper Preg 13:245-252, 1994.
26. Sibai BM: Magnesium sulfate is the ideal anticonvulsant in preeclampsia-eclampsia. Am J Obstet Gynecol 162:1141-1145, 1990.
27. Dommisse J: Phenytoin sodium and magnesium sulphate in the management of eclampsia. Br J Obstet Gynaecol 97:104-109, 1990.
28. Crowther C: Magnesium sulphate versus diazepam in the management of eclampsia: A randomized controlled trial. Br J Obstet Gynaecol 97:110-117, 1990.
29. Ryan G, Lange IR, Naugler MA: Clinical experience with phenytoin prophylaxis in severe preeclampsia. Am J Obstet Gynecol 161:1297-1304, 1989.
30. Friedman SA, Lim K-H, Baker CA, Repke JT: Phenytoin versus magnesium sulfate in pre-eclampsia: A pilot study. Am J Perinatol 10:233-238, 1993.
31. Eclampsia Trial Collaborative Group: Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 345:1455-1463, 1995.
32. Department of Health, Welsh Office, Scottish Home and Health Department, Department of Health and Social Security, Northern Ireland: "Report on Confidential Enquiries Into Maternal Deaths in the United Kingdom 1988-1990. London: HM Stationery Office, 1994.
33. Duley L: Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol 99:547-553, 1992.
34. McGuiness GA, Weinstein MM, Cruikshank DP, Pitkin RM: Effects of magnesium sulfate treatment on perinatal calcium metabolism. II. Neonatal responses. Obstet Gynecol 56:595-600, 1980.
35. Burrows RF, Burrows EA: The feasibility of a control population for a randomized control trial of seizure prophylaxis in the hypertensive disorder of pregnancy. Am J Obstet Gynecol 173:929-935, 1995.
36. Ylikorkala O, Makila UM, Kaapa P, Viinikka L: Maternal ingestion of acetylsalicylic acid inhibits fetal and neonatal prostacyclin and thromboxane in humans. Am J Obstet Gynecol 155:345-349, 1986.
37. Barton JR, Sibai BM: Low-dose aspirin to improve perinatal outcome. Clin Obstet Gynecol 34:251-261, 1991.
38. Beaufils M, Uzan S, Donsimoni R, Colau JC: Prevention of preeclampsia by early antiplatelet therapy. Lancet 2:840-842, 1985.
39. Wallenburg HLS, Dekker GA, Makowitz JW: Low-dose aspirin prevents pregnancy-induced hypertension and preeclampsia in angiotensin-sensitive primigravidae. Lancet 1:1-3, 1986.
40. Benigni A, Gregorini G, Frusca T, Chiabrando C, Ballerini S, Valcamonico A, Orisio S, Piccinelli A, Piniroli V, Fanelli R, Gastaldi A Remuzzi G: Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk of pregnancy-induced hypertension. N Engl J Med 321:357-362, 1989.
41. Schiff E, Peleg E, Goldenberg M, Rosenthal T, Ruppin E, Tamarkin M, Barkai G, Ben-Baruch G, Uahal I, Blankstein J, Goldman B, Mashiach S: The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med 321:351-356, 1989.
42. Dekker GA, Sibai BM: Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: Rationale, mechanisms, and clinical trials. Am J Obstet Gynecol 168:214-227, 1993.
43. Sibai BM, Caritis SN, Thom E, Klebanoff M, McNellis D, Rocco L, Paul RH, Romero R, Witter F, Rosen M, Depp R, and the NICHD Network: Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med 329:1213-1218, 1993.
44. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9384 pregnant women. Lancet 343:619-629, 1994.
45. Italian Study of Aspirin in Pregnancy: Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy induced hypertension. Lancet 341:753-754, 1993.
46. Belizan JM, Villar J: The relationship between calcium intake and edema proteinuria- and hypertension-gestosis: An hypothesis. Am J Clin Nutr 33:2202-2210, 1980.
47. Belizan JM, Villar J, Repke J: The relationship between calcium intake and pregnancy-induced hypertension: Up-to-date evidence. Am J Obstet Gynecol 158:898-902, 1988.
48. Belizan JM, Villar J, Gonzalez L, Campodonico L. Bergel E: Calcium supplementation to prevent hypertensive disorders of pregnancy. N Engl J Med 325:1399-1405, 1991.
49. Caroli G, Duley L, Belizan JM, Villar J: Calcium supplementation during pregnancy: A systematic review of randomised controlled trials. Br J Obstet Gynaecol 101:753-758, 1994.